Related Experiment Videos
Diagnostic delay in pediatric solid tumors: a population based study on determinants and impact on outcomes
Amos Hong Pheng Loh1, LeLe Aung, Christina Ha
1Department of Pediatric Surgery, KK Women's and Children's Hospital, Singapore, Singapore. amos.loh.hp@kkh.com.sg
Pediatric Blood & Cancer
|November 5, 2011
Summary
Diagnostic delays in pediatric tumors are linked to patient age and tumor site, but not overall outcomes. Early detection by healthcare professionals and pediatric emergency units can shorten diagnosis times.
Area of Science:
- Pediatric Oncology
- Epidemiology
- Health Services Research
Background:
- Pediatric tumors often present at advanced stages, potentially due to diagnostic delays.
- Understanding factors contributing to delayed diagnosis is crucial for improving outcomes in childhood cancers.
Purpose of the Study:
- To identify factors associated with diagnostic delay in pediatric tumors.
- To assess the impact of diagnostic delay on the stage and outcome of pediatric cancers.
Main Methods:
- Retrospective analysis of 390 pediatric tumors from the Singapore Childhood Cancer Registry (1997-2007).
- Multivariate linear regression used to correlate diagnostic delay with socio-demographic, disease, and healthcare system factors.
- Cox regression analysis assessed the association between delay and event-free survival (EFS).
Main Results:
- Median diagnostic delay was 5.3 weeks; younger age, abdominal/pelvic tumor sites, and incidental diagnoses were associated with shorter delays.
- Pediatric emergency units as first contact and first suspicion points correlated with reduced delay.
- Identified factors explained only 21% of the variance in delay times.
- No significant association found between delay and event-free survival or disease stage (24% presented at Stage 4).
Conclusions:
- Diagnostic delay in pediatric tumors is influenced by patient age, tumor site, and initial healthcare interactions.
- Despite identified associations, the analyzed factors accounted for a small proportion of the observed delay variability.
- Overall diagnostic delays were relatively short and did not significantly impact disease stage at presentation or patient outcomes.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...